Fungi
- Fysiobasen
- 1h
- 3 min read
FungiĀ are unicellular or multicellular eukaryotic organismsĀ found everywhere in nature. From large macroscopic species such as mushrooms and molds to microscopic yeasts, fungi exhibit remarkable morphological diversity.
While most fungi are harmless to humans, some can cause disease under specific conditions.

Public Health and Global Significance
Fungal infections kill over 1.5 million people each yearĀ and affect more than one billion globallyĀ [1][2]. Despite this, they remain a neglected public health issue, even though most deaths could be prevented with timely diagnosis and accessible treatment.
Severe fungal infections often occur as complications of underlying conditionsĀ such as:
Asthma
AIDS/HIV
Cancer
Organ transplantation
Immunosuppressive therapy
Transmission and Pathogenesis
Fungi reproduce through sporesĀ that spread via direct contact or inhalation.
Infections most commonly affect the skin, nails, and lungs, but fungi can also penetrate the skin barrier, invade organs, and cause systemic infectionsĀ [3].
Many fungal infections are chronic and difficult to treat, with invasive mycoses often requiring months to yearsĀ of therapy.
Unique Characteristics of Fungal Infections
Often chronicĀ and potentially fatalĀ if untreated.
Low contagion rateĀ compared to bacterial or viral diseases, which contributes to limited public health awarenessĀ [4].
Certain chronic infections, such as chromoblastomycosisĀ and eumycetoma, can cause disfigurement, social isolation, and functional impairmentĀ [5].
Epidemiology
Fungal infections represent a major global disease burden:
Chronic pulmonary aspergillosis:Ā ~3 million cases annually
Cryptococcal meningitis (HIV/AIDS-related):Ā ~223,100 cases and 181,000 deaths per year, mainly in sub-Saharan Africa
Invasive candidiasis:Ā ~700,000 cases
Invasive aspergillosis:Ā ~250,000 cases
Histoplasmosis:Ā ~100,000 cases
Fungal asthma:Ā ~10 million cases worldwide [1]
Pneumocystis pneumonia:Ā >400,000 deaths yearly in untreated patients
Emerging Threats and Medical Context
Systemic fungal infections were rare before the 1950s, but modern medicine has created new opportunities for fungi to infect vulnerable hosts.Risk factors include:
Antibiotic use
Intensive care unit (ICU) treatment
Immunosuppressive therapy
Chemotherapy
Mortality rates for invasive fungal infections remain high ā 30ā90%, depending on the pathogen and patient group [6].
Superficial and Invasive Infections
Superficial infections:Affect skin, hair, and nails, impacting over 1 billion peopleĀ worldwide.
Mucosal infections:Candida species causing oral or vaginal candidiasis.
Chronic subcutaneous infections:Include mycetomaĀ and chromoblastomycosis, classified as neglected tropical diseases.
Chronic pulmonary fungal infections:Often develop as complications of tuberculosisĀ or other chronic lung diseases.
Fungal allergies:Contribute to worsening of asthma, cystic fibrosis, and chronic sinusitis.
Invasive fungal infections:Life-threatening, requiring rapid diagnosis and targeted antifungal therapy.
Common Fungal Infections in Humans
Aspergillosis:Ā Severe lung infection in immunocompromised individuals.
Blastomycosis:Ā Primarily pulmonary, may spread to skin and bones.
Candida albicans:Ā Causes oral, vaginal, and systemic infections.
Chromoblastomycosis:Ā Chronic skin/subcutaneous infection, tropical or subtropical regions.
Coccidioidomycosis:Ā Pulmonary infection with fever and rash, common in the USA and Mexico.
Cryptococcosis:Ā Lung and CNS infection in AIDS patients.
Tinea pedis (athleteās foot):Ā Common superficial fungal infection.
Histoplasmosis:Ā Acute flu-like or chronic, potentially fatal lung infection.
Mucormycosis:Ā Aggressive opportunistic infection.
Onychomycosis:Ā Nail fungus, common in elderly and diabetic individuals.
Paracoccidioidomycosis:Ā Endemic in South and Central America.
Pneumocystis pneumonia:Ā AIDS-related, fatal if untreated.
Sporotrichosis:Ā Chronic skin infection (ārose gardenerās diseaseā).
Tinea versicolor/cruris:Ā Superficial skin infections, common in tropical climates [7][8].
Conclusion
Fungal diseasesĀ represent a major yet underestimated global health challenge. Their chronic progression, complex pathogenesis, and high mortality ratesĀ in invasive cases demand greater attention from public health systems.Improved diagnostic tools, access to antifungal therapies, and vaccine developmentĀ (where possible) are critical steps toward reducing global fungal disease burden.
References:
Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseasesāestimate precision. Journal of fungi. 2017 Dec;3(4):57.;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753159/
McKeny PT, Zito PM. Antifungal Antibiotics.2020 :https://www.ncbi.nlm.nih.gov/books/NBK538168/
Healthline Fungal Infections :https://www.healthline.com/health/fungal-infection#types
Casadevall A. Fungal diseases in the 21st century: the near and far horizons. Pathogens & immunity. 2018;3(2):183.:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241320/
Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS neglected tropical diseases. 2020 Feb 20;14(2):e0007964 :.https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007964
Fisher MC, Gurr SJ, Cuomo CA, Blehert DS, Jin H, Stukenbrock EH, Stajich JE, Kahmann R, Boone C, Denning DW, Gow NA. Threats posed by the Fungal Kingdom to humans, wildlife, and agriculture. mBio. 2020 Jun 30;11(3).:https://mbio.asm.org/content/11/3/e00449-20#sec-2
Gupta AK, Ricci MJ. Diagnosing onychomycosis. Dermatol Clin. 2006;24(3):365ā9.
The free dictionary Available from:https://medical-dictionary.thefreedictionary.com/sporotrichosis





